QLIFE HOLDING AB INTERIM REPORT Q2, 2021
Successful capital raise and sales partnershipFINANCIAL SUMMARY – SECOND QUARTER 2021 · Revenue in the period amounted to kSEK 10,482 (6,181). Sales regards COVID-19 tests from the test service center as well as Egoo.Health devices and capsules for decentralized testing. · EBITDA for the period amounted to kSEK -8,107 (-2,147), and net loss kSEK -11,327 (-1,138). · The positive cash flow is related to the new issue of shares and exercise of warrants (TO1). · The total cash flow in the second quarter amounted to kSEK 98,771 (-5,774). · Earnings per share before/after